StonvexLoading…
StonvexStonvexStonvexCore line items from AGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-04 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $258.59M | $944.61M | $682.56M | $431.40M | $193.66M |
Operating Income | Not available | $134.70M | $87.03M | $54.40M | $24.34M |
Net Income | Not available | $137.77M | $88.56M | $57.83M | $22.55M |
EPS (Diluted) | $2.33 | $9.74 | $6.27 | $4.09 | $1.60 |
Total Assets | Not available | $1.19B | $1.05B | $882.70M | $792.15M |
Total Liabilities | Not available | $724.09M | $631.16M | $489.53M | $428.26M |
Cash & Equivalents | Not available | $339.48M | $306.29M | $177.85M | $189.25M |
Free Cash Flow OCF − CapEx | Not available | $410.84M | $239.72M | $67.81M | $34.90M |
Shares Outstanding | Not available | 13.95M | 13.87M | 13.81M | 13.64M |